Investor Ideas Potcasts, Cannabis News and Stocks on the Move: (TSX: TGOD) (TSX: WBR) (CSE: TTT) (CSE: AGRO) (CSE: TER)
Delta, Kelowna, BC - August 14, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts, #Cannabis News and Stocks on the Move: (TSX: TGOD) (TSX: WBR) (CSE: TTT) (CSE: AGRO) (CSE: TER)
In today's podcast we look at a few early announcements.
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) reported its financial and operational results for the three and six months ended June 30, 2019. These filings are available for review on the Company's SEDAR profile at www.sedar.com.
- Is nearing completion of construction at its Hamilton site and Phase 1 at its Valleyfield site, with investment amounting to $53.1 million in the second quarter of 2019, bringing the total additions year to date to $100.9 million.
- Achieved revenues of $2.9 million, a 20% increase over the prior quarter derived primarily from Europe. In Canada, the Company launched its pilot "Grower's Circle", which included sales to a small number of medical patients to test the market and the Company's distribution capabilities. The Company launched two new products in Q2 and expects to start a similar pilot in the Ontario recreational market during Q3-2019.
- Experienced a net loss of $16.6 million for Q2-2019. Management continued to maintain a disciplined approach to operational costs as it prepares for commercialization of its products in Canada and internationally.
Other key updates in the quarter
- Announced provincial board supply agreements with Alberta Cannabis and BC Cannabis Stores, expanding its footprint in Western Canada.
- Achieved its organic certification for the Valleyfield facility from Pro-Cert, an internationally recognized organic certification organization.
- Signed a distribution agreement with Mediakos UG haftunsbeschraenkt to be the exclusive distributor of CannibiGold, HemPoland's premium hemp CBD brand, for the German pharmacy market. In addition, the Company launched its Global Strategic Hemp Division.
- Entered into a multi-year agreement with Neptune Wellness Solutions Inc. for extraction, formulation and packaging services. As part of the agreement, the Company will have exclusivity on extraction, formulation and packaging of certified organic products within and for the Canadian market.
"Q2 was pivotal for the Company as we began commercial production in the second phase of our Hamilton site and expanded our product line for the Grower's Circle," commented Brian Athaide, CEO of TGOD. "The product quality feedback from the Grower's Circle has been overwhelmingly positive, confirming that patients appreciate having access to premium certified organic cannabis, an underserved segment of the market. With double digit quarterly growth in Europe and construction nearing completion in Canada, the team continues to deliver on our ambitious business plan with executional excellence. We now have our first purchase order from the OCS in hand and look forward to shipping our first recreational sales this week," continued Athaide.
Waterloo Brewing Ltd. (TSX: WBR), Ontario's largest Canadian-owned brewery, today announced receipt of its research license for cannabis-infused beverages. The Company is on track to be ready to commercially produce such products for 2020.
"The cannabis market has garnered a great deal of investor interest and after an in-depth review of our strategic options, the Company is positioning itself to be a major producer of CIB's and to take full advantage of this new and developing beverage category," stated George Croft, President and CEO, Waterloo Brewing. "We plan to be the production partner of choice for the beverage cannabis business."
"Cannabis-infused beverages is an unprecedented growth opportunity with an estimated market value of $1.5 billion," concluded Croft "and we are now in a highly advantaged position to deliver significant value for our investors."
"We believe that due to technical infrastructure issues related to the licensing and commercial production of cannabis-infused beverages, we will be one of the few beverage production facilities capable of producing these products," said Russell Tabata, Chief Operating Officer. "We have the equipment, the scale, the technical know-how and the speed to be able to pull this off in this extremely tight timeframe," added Mr. Tabata.
Shoppers Drug Mart today announced the successful completion of Phase 1 of its blockchain-secured pilot program with software partner TruTrace Technologies Inc. (CSE: TTT) (OTCQB: TTTSF). The Pilot Program is specifically designed to increase transparency, interoperability and product identification within the medical cannabis industry. Shoppers has now engaged TruTrace and Deloitte Canada LLP to execute Phase 2 of the Pilot Program, with full production and implementation of TruTrace's StrainSecure platform targeted for late November 2019.
Phase 2 of the Pilot Program, using Deloitte's project management and advisory capacity and TruTrace's StrainSecure™ system, will be focused on developing a unified approach to medical cannabis standards, onboarding licenced producers and other partners to track and trace all product history-from genome to distribution. The program is expected to help researchers and clinicians to match therapeutic outcomes to specific genetic and chemical profiles, and provide physicians, pharmacists, and patients with greater confidence in the products they prescribe or consume.
Under their StrainSecure™ system, the TruTrace team collects plant testing data and performs genomic verification in plant batches which are then registered in a blockchain-enabled database for intellectual property protection and strain validation. All information gathered from the plants, including their molecular and chemical makeup, can be tracked via the technology.
"We have been encouraged by the response to this traceability initiative. There is a clear consensus within the cannabis industry that the source and quality of medical cannabis must be transparent and identifiable in order to meet the expectations of patients and health care practitioners," said Ken Weisbrod, Vice President of Business Development, Shoppers Drug Mart. "It is more important than ever to be able to assure all stakeholders, from regulators to health care practitioners, that the medical cannabis industry is taking the necessary steps to establish the infrastructure required to deliver standardized, consistent medication to our patients. Shoppers has turned to two trusted leaders, TruTrace and Deloitte Canada LLP, to assist us in the second phase of the project."
"As the cannabis sector continues to rapidly evolve in Canada, the industry needs to increase transparency to all stakeholders by demonstrating adherence to rigorous procedures to maintain the overall integrity of the supply chain," said David Stewart, Partner within Deloitte's Forensics practice. "Strengthening traceability and verification of cannabis products will bring benefits to the industry as a whole, and most importantly, build confidence and accountability into the cannabis medical value chain. We are proud to be part of such an important initiative given Deloitte Canada's leadership in the cannabis space."
Arable soil scarcity, climate change and higher recurrence of extreme weather events are prompting a shift from outdoor to indoor farming which has eco sustainable methods and less environmental impact. According to GBC, an independent research firm, Agrios, a developer of disruptive technology in the field of agri-tech, is "entering a growth phase" as the global need for agri-tech innovations to support eco-sustainable agronomy increases.
Agrios' data-driven aeroponic technology can be used for any type of indoor cultivation. The Company's aeroponic cultivation facilities are equipped with high precision sensors collecting actionable data on 32 key cultivation metrics. Real time data is sent to Agrios' proprietary software, where data analytics allow for precision cultivation, enabling control of numerous variables, including but not limited to, temperature, humidity, lighting, air quality, water, and nutrients.
Agrios' state-of-the-art aeroponic technologies are an attractive solution for the cannabis cultivation industry as cannabis requires specific conditions to grow well and cultivators must ensure these conditions are optimized. Aeroponics greatly reduces the uncertainty of the growing process and makes the duplication of results from one growth cycle to the next one possible.
A major factor in the production of cannabis is the cost of production and achieving consistent product quality. The table below provides an overview of the costs of several cultivation methods. While the cost to produce is lower in an outdoor grow facility, producers are limited to cultivating between one to two crops annually, where Agrios' aeroponic cultivation clients can harvest an average of five times per annum.
Comparatively, growers that use Agrios' indoor aeroponic platform can produce premium quality flower for approximately $1.00 per gram, with higher yields of between 2.5 and 4.0 kilograms per m² annually, nearly five times that of greenhouse yields and ten times that of outdoor yields.
"Agrios' data-driven aeroponics platform is highly advantageous to cannabis cultivators, as it substantially lowers operating costs in the areas of energy, labor, nutrient and water consumption, enabling our clients to remain competitive in today's cannabis market." said Chris Kennedy, President & CEO of Agrios Global Holdings.
TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) today announced that it has completed its first international shipment of dry cannabis flower to its German distribution partner iuvo Therapeutics GmbH. The shipment was made from TerrAscend's EU GMP certified manufacturing facility in Mississauga, Ontario, Canada. As the Company ships additional product to Germany in partnership with iuvo, it will continue to expand its footprint in Europe and other international markets. The Company looks forward to providing investors with updates on such expansion activities.
TerrAscend and iuvo, respectively were granted an Export Permit by Health Canada, under the Cannabis Act, and an Import Authorization from Germany's Federal Institute for Drugs and Medical Devices, following the issuance of the Company's EU Good Manufacturing Practice ("GMP") certificate on April 29, 2019. TerrAscend is one of only six companies with a GMP certified cannabis facility.
It is expected that the German cannabis market will generate more than $5 billion in revenue by 2025. With more than 30,000 current medical cannabis patients in Germany and upwards of 7,200 kg in annual medical patient consumption, the TerrAscend-iuvo partnership presents an exciting opportunity to fulfill the growing needs of medical cannabis patients in Germany.
"We look forward to bringing TerrAscend's quality products to the German market and working with a partner who is also focused on patient well-being," said Robyn Rabinovich, VP, Cannabis Strategy and Partnerships, "This first shipment solidifies our partnership with iuvo and will allow for ongoing access to high quality medical cannabis products for German patients."
"We are pleased to commence our first shipment to Germany together with our partner TerrAscend." Said Daniel Seidi, Director and Co-Founder of iuvo "In close collaboration we have successfully established a fully EU GMP/GDP licenced supply-chain of our pharmaceuticals. This places us in a unique position to respond to the supply-deficiency within the EU in the interest of the patients in need."
THORNTON GROUT FINNIGAN LLP AND ROCHON GENOVA LLP have together commenced a class action in Ontario on behalf of shareholders of CannTrust Holdings Inc. (TSX: TRST) (NYSE: CTST) who acquired their CannTrust common shares between October 1, 2018 up to and including July 8, 2019. The class action seeks damages from CannTrust, certain of its officers and directors, and its auditors KPMG, arising out of alleged misrepresentations in CannTrust's required public disclosure, including its 2018 audited annual financial statements.
Joel P. Rochon, Managing Partner at Rochon Genova, said: "Accurate and timely public disclosure is the lifeblood of our capital markets. Investors are entitled to full, true and plain disclosure about Ontario reporting issuers. Proper disclosure levels the playing field among all investors and enables them to make informed decisions."
John L. Finnigan, Founding Partner at Thornton Grout Finnigan, said: "The integrity of our capital markets depends upon timely and accurate corporate disclosure. Gatekeepers, such as auditors, play a critical role in protecting investors; and this is particularly so when dealing with a nascent industry like cannabis."
Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media